ADDF and NYAS Issue Challenge Grant to Accelerate Drug Development for Alzheimer's Disease and Dementia

June 27, 2013

ADDF and NYAS Issue Challenge Grant to Accelerate Drug Development for Alzheimer's Disease and Dementia

Progress in developing effective Alzheimer's disease and dementia therapeutics has been hampered by a lack of short-term, sensitive biomarkers that correlate closely to clinical outcomes. The Alzheimer's Drug Discovery Foundation (ADDF) is partnering with the New York Academy of Sciences (NYAS) to issue a challenge grant for the development and validation of biomarkers that meet this need. Higher priority will be given to applications that involve cross-sector or interdisciplinary collaborations and truly novel ideas.

Priority areas for this Request for Proposals (RFP) include:

  • Biomarkers of early-disease progression
  • Biomarkers related to neurovascular dysfunction
  • Biomarkers relevant to disease cell-to-cell transmission and spread of tau pathology
  • Dynamic biomarkers with sensitivity to detect short-term or immediate changes

Mechanism(s) of Support: $140,000 in funding is available for one-year duration with the possibility of follow-on funding. Applications may be submitted by non-profit academic institutions, worldwide. The deadline date for applications is August 1, 2013. Submission of a Letter of Intent (LOI) is required prior to July 25, 2013. View the full RFP here.

For other open funding opportunities through the ADDF, please visit the ADDF Web site.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.